UnitedHealth Group Inc (NYSE:UNH) – Equities research analysts at Cantor Fitzgerald increased their FY2018 earnings per share estimates for UnitedHealth Group in a research note issued to investors on Wednesday. Cantor Fitzgerald analyst S. Halper now forecasts that the healthcare conglomerate will earn $12.40 per share for the year, up from their prior estimate of $10.80. Cantor Fitzgerald currently has a “Overweight” rating and a $280.00 target price on the stock.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, beating analysts’ consensus estimates of $2.50 by $0.09. The firm had revenue of $52.06 billion during the quarter, compared to analysts’ expectations of $51.57 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The company’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same quarter last year, the company posted $2.11 earnings per share.
Shares of UnitedHealth Group (UNH) traded up $0.19 during mid-day trading on Friday, reaching $243.35. 4,279,283 shares of the company’s stock were exchanged, compared to its average volume of 3,634,767. The firm has a market capitalization of $234,890.00, a PE ratio of 22.72, a P/E/G ratio of 1.45 and a beta of 0.66. UnitedHealth Group has a 12-month low of $156.49 and a 12-month high of $243.90. The company has a current ratio of 0.73, a quick ratio of 0.70 and a debt-to-equity ratio of 0.58.
In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction dated Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total value of $1,250,536.00. Following the transaction, the director now directly owns 61,137 shares of the company’s stock, valued at approximately $13,652,503.47. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Larry C. Renfro sold 22,598 shares of the firm’s stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the completion of the transaction, the chief executive officer now directly owns 195,314 shares in the company, valued at $43,310,879.50. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 33,655 shares of company stock worth $7,469,083. 0.89% of the stock is owned by insiders.
A number of hedge funds have recently added to or reduced their stakes in UNH. Blue Chip Partners Inc. acquired a new stake in shares of UnitedHealth Group in the 2nd quarter valued at approximately $110,000. Bruderman Asset Management LLC acquired a new stake in shares of UnitedHealth Group in the 2nd quarter valued at approximately $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its stake in shares of UnitedHealth Group by 433.3% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after purchasing an additional 520 shares in the last quarter. BDO Wealth Advisors LLC acquired a new stake in shares of UnitedHealth Group in the 2nd quarter valued at approximately $121,000. Finally, Acrospire Investment Management LLC boosted its stake in shares of UnitedHealth Group by 130.7% in the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock valued at $131,000 after purchasing an additional 400 shares in the last quarter. 86.09% of the stock is currently owned by hedge funds and other institutional investors.
WARNING: This piece of content was originally published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international copyright laws. The original version of this piece of content can be read at https://www.americanbankingnews.com/2018/01/19/research-analysts-issue-forecasts-for-unitedhealth-group-incs-fy2018-earnings-unh.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.